Physician profile
Barbara Tapps
NPI 1316158900
$2,140.99
in general payments reported to CMS, 2019-2025
21 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $401 · 2022: $886 · 2023: $709 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $334.56 | 2021-2023 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $271.00 | 2022-2023 | Breztri, Farxiga |
| Axsome Therapeutics, INC. | $249.22 | 2023-2025 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $239.92 | 2021-2025 | Austedo, Austedo Xr |
| Gen-Probe Sales & Service, INC. | $141.38 | 2022 | |
| Lilly USA, LLC | $131.36 | 2021-2023 | Mounjaro |
| Avanir Pharmaceuticals, INC. | $124.99 | 2022 | |
| Abbvie INC. | $122.58 | 2022 | |
| Grt US Holding, INC. | $109.95 | 2022 | |
| Abbott Laboratories | $58.80 | 2022-2023 | Freestyle Libre 2 |
| Sk Life Science, INC. | $54.66 | 2023 | Xcopri |
| Collegium Pharmaceutical, INC. | $47.27 | 2021-2022 | |
| Amgen INC. | $43.40 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $36.54 | 2021 | |
| Biodelivery Sciences International, INC. | $31.08 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $30.78 | 2022-2023 | |
| Hikma Pharmaceuticals USA | $30.52 | 2022 | |
| Janssen Pharmaceuticals, INC | $27.53 | 2023 | Xarelto |
| Arbor Pharmaceuticals, INC. | $22.86 | 2021 | |
| Medtronic, INC. | $20.32 | 2023 | Intellis Adaptivestim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Tapps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.